期刊文献+

淋巴瘤并发静脉血栓25例的临床分析 被引量:1

Clinical analysis of 25 cases of lymphoma complicated with venous thromboembolism
下载PDF
导出
摘要 目的:分析淋巴瘤合并静脉血栓患者的临床特点。方法:回顾性分析25例淋巴瘤合并静脉血栓患者的临床资料。结果:20例非霍奇金淋巴瘤(NHL),5例霍奇金淋巴瘤(HL)。8例患者在淋巴瘤确诊前8~50天确诊为VTE,16例患者化疗第2或3个周期时确诊VTE。结论:深静脉置管与化疗是淋巴瘤患者合并静脉血栓的重要诱因。 Objective:To analyze the clinical characteristics of patients with lymphoma complicated with venousthromboembolism.Methods:The clinical data of 25 cases of patients with lymphoma complicated with venous thromboembolismwere analyzed retrospectively.Results:20 cases had non Hodgkin's lymphoma(NHL),5 cases had Hodgkin's lymphoma(HL).8 casesof patients were diagnosed as VTE 8 to 50 days before diagnosed as lymphoma,and 16 cases of patients were diagnosed as VTEwith second or third cycles of chemotherapy.Conclusion:Deep venous catheterization and chemotherapy were important factors forthe patients with lymphoma complicated with venous thromboembolism.
作者 林聪猛 林达义 Lin Congmeng;Lin Dayi(Department of Hematology,Zhangzhou Hospital Affiliated to Fujian Medical University 363000)
出处 《中国社区医师》 2015年第36期58-58,60,共2页 Chinese Community Doctors
关键词 淋巴瘤 静脉栓塞 特征 Lymphoma Venous thromboembolism Characteristics
  • 相关文献

参考文献3

二级参考文献33

  • 1Blom JW,Doggen CJ,Osanto S,et al.Malignancies,prothrombotic mutations,and the risk of venous thrombosis.JAMA,2005,293:715-722.
  • 2Levitan N,Dowlati A,Remick SC,et al.Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy.Risk analysis using Medicare claims data.Medicine (Baltimore),1999,78:285-291.
  • 3Wells PS,Hirsh J,Anderson DR,et al.Accuracy of clinical assessment of deep-vein thrombosis.Lancet,1995,345:1326-1330.
  • 4Lee AY,Levine MN.Management of venous thromboembolism in cancer patients.Oncology(Williston Park),2000,14:409-417,421,422,425-426.
  • 5Koopman MM,Prandoni P,Piovella F,et al.Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.The Tasman Study Group.N Engl J Med,1996,334:682-687.
  • 6Merli G,Spiro TE,Olsson CG,et al.Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.Ann Intern Med,2001,134:191-202.
  • 7Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.The Columbus Investigators.N Engl J Med,1997,337:657-662.
  • 8Hutten BA,Prins MH,Gent M,et al.Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio:a retrospective analysis.J Clin Oncol,2000,18:3078-3083.
  • 9Prandoni P,Lensing AW,Piccioli A,et al.Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.Blood,2002,100:3484-3488.
  • 10Meyer G,Marjanovic Z,Valcke J,et al.Comparison of lowmolecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer:a randomized controlled study.Arch Intern Med,2002,162:1729-1735.

共引文献29

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部